USA
COA ON FILEMADE IN USA
Capsules
BPC-157 Capsules
$89.99
Description
BPC-157, a synthetic pentadecapeptide, in capsule format for formulation research. Each batch has its own certificate of analysis (COA), which opens when you scan the QR code on the label. For laboratory research use only. Not for human or veterinary use.
Research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure or prevent any disease.
Research profile
BPC-157 research profile
BPC-157 is a synthetic 15-residue peptide whose sequence is a partial sequence of a protein ("body protection compound") described in human gastric juice. It was first reported by Sikirić and colleagues at the University of Zagreb in 1993 and has since been studied mainly in rodent models.
Specifications
- Sequence
- Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV)
- Molecular formula
- C62H98N16O22
- Molecular weight
- ≈ 1419.6 g/mol
- CAS number
- 137525-51-0
- Form
- Supplied in capsule format
- Storage
- Keep sealed, protected from light and moisture; follow the label
- Testing
- HPLC purity and mass spectrometry identity, per lot. Scan the QR code on the vial for the certificate of analysis.
Published research
- Tendon and ligament models: rat Achilles tendon transection with in vitro tendocyte culture (Staresinic et al., J Orthop Res, 2003); rat ligament models (Cerovecki et al., J Orthop Res, 2010).
- Tendon fibroblasts in culture: Chang et al., J Appl Physiol, 2011.
- Gastrointestinal models: rodent colitis, anastomosis and ischemia studies (e.g. Duzel et al., World J Gastroenterol, 2017).
- Angiogenesis: rat hind-limb ischemia and endothelial cell culture, VEGFR2 expression (Hsieh et al., J Mol Med, 2017).
- Pharmacokinetics and preclinical safety in rats and dogs (He et al., Front Pharmacol, 2022). A 2025 review (Józwiak et al., Pharmaceuticals) notes no completed human efficacy studies.
Frequently asked questions
What is the sequence of BPC-157?
GEPPPGKPADDAGLV, a 15-amino-acid peptide with a molecular weight of about 1419.6 g/mol.
Where does BPC-157 come from?
It is synthetic. Its sequence is a partial sequence of a protein described in human gastric juice, first reported by Sikirić and colleagues in 1993.
How do I verify my lot?
Scan the QR code on the vial. It opens the certificate of analysis for that lot, with HPLC purity and the mass spectrometry identity result.
For laboratory research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure or prevent any disease. Literature references are provided for scientific context and do not describe this product's suitability for any use.
More in Capsules
You might also need.
BPC-157 vs TB-500: two research peptides compared · Reading a mass spectrum on a peptide COA: m/z, charge states and adducts · GHK-Cu blends explained: GLOW and KLOW compositions · CJC-1295 with and without DAC: what the names mean · Short peptide bioregulators: an overview for researchers · Why a peptide's molecular weight can differ: salts, caps and oxidation · Thymosin alpha-1: structure, history and research · Epitalon (AEDG): what the research covers · KPV: the α-MSH tripeptide explained · MOTS-c: the mitochondrial-derived peptide explained · Adamax and Semax: what is known about this analog · Selank: the tuftsin-derived heptapeptide explained · SNAP-8 vs Argireline: two SNAP-25 mimic peptides compared · AHK-Cu vs GHK-Cu: comparing two copper tripeptides · GHK-Cu: structure, history and published research · HPLC purity: what the percentage on a COA means · Mass spectrometry: how a peptide's identity is confirmed · How to verify a lot with the QR code on the vial · Lyophilized peptides: what they are and how labs store them · How to choose a research compound supplier: 7 points